Overview
Case Submission
View Archive

Accreditation/
Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from GlaxoSmithKline.

Reflective Case-Based Oncology Collective™: Real-World Applications for PARP Inhibition in Ovarian Cancer Clinical Practices

Reflective Case-Based Oncology Collective™: Real-World Applications for PARP Inhibition in Ovarian Cancer Clinical Practices


August 18, 2021

Exclusive, virtual, and highly interactive case-based learning session!

6:00 PM – 8:00 PM EDT

To register for this exclusive event, please send your email address and a contact phone number to info@gotoper.com or call (888) 949-0045 or (609) 378-3701.

Participation for this event is strictly limited to 12 participants, so register today!

Overview

This activity combines a core curriculum, developed by a steering committee of renowned experts in the medical management of ovarian cancer, with real-world cases that challenge learners to reflect on the application of the evidence to their own clinical practices. The Reflective Case-Based Oncology Collective™ brings clinical experts and community oncologists together, virtually, to collectively consider the ramifications on care of new approaches to treatment including the most appropriate and efficacious incorporation of PARP inhibitors into clinical management of patients with ovarian cancer.

Currently, there are several PARP inhibitors approved or in clinical development for ovarian cancer. Key trial data will be discussed as well as optimal strategies for incorporating these agents into treatment of patients. PARP inhibitors exhibit a significantly different toxicity profile from traditional chemotherapy agents and therefore key safety data will be carefully addressed. The practical, case-based format of this program will focus on the use of PARP inhibitors by multidisciplinary teams for management of real-world patients with ovarian cancer.

Benefits of Attending

  • Direct interaction with world-renowned experts in ovarian cancer management and PARP use
  • Hear varied perspectives on how to manage your most challenging real-world cases
  • Learn ways to monitor for and mitigate adverse events in your patients with ovarian cancer
  • Incorporate recent clinical trial data into your clinical practice with confidence

Acknowledgment of Commercial Support

This activity is supported by educational grants from GlaxoSmithKline.

Target Audience

The live activity series is directed toward medical oncologists who treat or manage patients with ovarian cancer. Surgical and radiation oncologists, pathologists, fellows, nurses, nurse practitioners, physician assistants, pharmacists, and other health care professionals interested in the treatment or management of these tumors are also invited to participate in the online activity.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Assess strategies utilized to integrate molecular testing with respect to current evidence and guidelines-based molecular testing recommendations for treatment selection in patients with newly diagnosed and recurrent ovarian cancer
  • Review the role of PARP inhibitors for patients with ovarian cancer in maintenance and treatment setting based on emerging data and evolving trends
  • Identify strategies utilized in the community to manage treatment-related toxicities associated with PARP inhibitor use and ensure these approaches are in line with guideline-based recommendations
  • Reflect on recent evidence and expert opinion guidance to incorporate state-of-the-art approaches to care for women with advanced ovarian cancer

Program Chair

Robert L. Coleman, MD, FACOG, FACS
Robert L. Coleman, MD, FACOG, FACS
Gynecologic Oncologist and Chief Scientific Officer
US Oncology Research
The Woodlands, TX

Disclosures: Grant/Research Support: ImmunoGen, Genmab/Seagen, AstraZeneca, Clovis Oncology, Merck & Co.; Consultant: Immunogen, Genmab/Seagen, AstraZeneca, Clovis Oncology, Merck & Co., GlaxoSmithKline, Toray, Deciphera Pharmaceuticals, Gradalis.

Faculty

Ramez N. Eskander, MD
Ramez N. Eskander, MD
Associate Clinical Professor of Gynecologic Oncology
Fellowship Director
Associate Residency Program Director
UC San Diego Moores Cancer Center
La Jolla, CA

Disclosures: Grant/Research Support: AstraZeneca, Clovis Oncology (institutional research support); Consultant: AstraZeneca, GSK, Clovis Oncology, Merck; Speaker’s Bureau: AstraZenca.

 
Kathleen Moore, MD
Kathleen Moore, MD
Professor of Obstetrics and Gynecology
Virginia Kerley Cade Chair in Developmental Therapeutics
Associate Director, Clinical Research
Director Phase I Clinical Trials
Stephenson Cancer Center
The University of Oklahoma College of Medicine
Oklahoma City, OK

Disclosures: Grant/Research Support: PTC Therapeutics, Lilly, Merck, GSK/Tesaro; Consultant: Astra Zeneca, Aravive, Eisai, GSK/Tesaro, Genentech/Roche, Immunogen, Merck, Myriad, Mersana, Elevar, VBL Therapeutics.

Registration

To register for this exclusive event, please send your email address and a contact phone number to info@gotoper.com or call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
 
Registration Fee - Free


For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.



Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
   1234
567891011
12131415161718
19202122232425
2627282930
Filter By